Science Career Fair 2012
Compaines that will participate in the events:
At Merck, around 40,000 people in 67 countries develop pharmaceutical, chemical and life science innovations. We operate our businesses in four divisions: Merck Serono, Consumer Health Care, Merck Millipore and Performance Materials.
- PHARMACEUTICALS: We discover, develop, manufacture and commercialize innovative prescription drugs and therapies for high unmet medical needs. Through their targeted effect, these help patients to live a longer and better life (Merck Serono). In addition, for the consumer health care market, we offer a wide range of over-the-counter products that help prevent illness and relieve minor complaints (Consumer Health Care).
- CHEMICALS: Our broad range of specialty chemicals are used in technologically sophisticated applications ranging from liquid crystal mixtures for ﬂ at-panel displays, to effect pigments and cosmetic ingredients (Performance Materials).
- LIFE SCIENCE: As a leading global partner to the life science industry,
we offer products, applications and solutions for protein research and cell biology as well as for the manufacture of chemical and biopharmaceutical drugs. Our products and services range from laboratory chemicals, reagents and consumables to analytical methods and laboratory water puriﬁ cation
systems (Merck Millipore).
The BioVenture Centre, located in Singapore's Biopolis, conducts life sciences research for BD. Our technology development programs are particularly aligned with urgent health care needs in developed and developing countries in the Asia Pacific region. Current programs include bioinformatics, genomics, cell biology, diabetes, and infectious disease diagnostics. BD is a medical technology company that serves health care institutions, life science researchers, clinical laboratories, industry, and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. The company is headquartered in the US and operates in over 50 countries. Over 29,000 associates provided critical products and services generating 2011 revenues of $7.8 billion.
Established in 2003, the Institute of Bioengineering and Nanotechnology (IBN) is spearheaded by its Executive Director, Professor Jackie Yi-Ru Ying, who was a Professor of Chemical Engineering at the Massachusetts Institute of Technology (1992 - 2005). In 2008, Professor Ying was recognized as one of “One Hundred Engineers of the Modern Era” by the American Institute of Chemical Engineers for her groundbreaking work on nanostructured systems, nanoporous materials and host matrices for quantum dots and wires. Under her direction, IBN conducts research at the cutting-edge of bioengineering and nanotechnology. Its programs are geared towards linking multiple disciplines across engineering, science and medicine to produce research breakthroughs that will improve healthcare and our quality of life.
IBN’s research activities are focused in the following areas:
- Drug and Gene Delivery, where the controlled release of therapeutics involve the use of functionalized polymers, hydrogels and biologics for targeting diseased cells and organs, and for responding to specific biological stimuli.
- Cell and Tissue Engineering, where biomimicking materials, stem cell technology, microfluidic systems and bioimaging tools are combined to develop novel approaches to regenerative medicine and artificial organs.
- Bio devices and Diagnostics, which involve nanotechnology and microfabricated platforms for highthroughput biomarker and drug screening, automated biologics synthesis, and rapid disease diagnosis.
- Pharmaceuticals Synthesis and Green Chemistry, which encompasses the efficient catalytic synthesis of chiral pharmaceuticals, and new nanocomposite materials for sustainable technology and alternative energy generation.
A joint collaboration between two educational powerhouses, Duke University in the United States and the National University of Singapore, Duke-NUS is committed to developing future leaders in medicine. Our 4-year graduate medical program is based on an innovative and highly rigorous curriculum, with the distinctive aim of developing researchers and practitioners who are exceptionally skilled in medical research and patient care.
Because it is impossible to teach medical students everything they'll ever need to know throughout their medical careers, our curriculum is a springboard, not an endpoint. We teach our students the fundamentals of medicine, research, and patient care, and how to become lifelong learners. It's this education that will make Duke-NUS graduates leaders, creative thinkers who will improve the practice of medicine.
As you prepare for your career in medicine, it's important to remember that it is no longer enough to keep on top of the latest medical advances. Those at the forefront of medicine are pioneers who can translate their passion for discovery into real solutions for the real world.
One of the primary goals of Duke-NUS is to help you make the most of your medical school education, and to develop the leaders who will play a fundamental role in translating medical research into future breakthroughs in patient care. If you can see yourself as one of those leaders, we welcome you to talk to our representatives at our booth.
For clients with high-tech or mission-critical projects, M+W Group’s expertise is a guarantee for best-in-class execution. As the leading global engineering and construction partner, the reach extends to Advanced Technology Facilities, Life Science & Chemicals, Energy and Environment Technologies, and High-Tech Infrastructure. Whether a turnkey or modular project, M+W Group sets industry benchmarks in quality, time-to-market and total cost of ownership. Our commitment to create value for customers has made us a partner of choice for global projects. Today, we proudly rank among the market leaders in sectors such as Semiconductors, Photovoltaic’s, Life Science, Science & Research, and Renewable Power Generation.
With many client relationships spanning decades, we have earned the trust that our commitment to protecting health, safety and the environment is as consistent as it is resolute.
MP Biomedicals is a worldwide corporation, with headquarters in Santa Ana, Calif., and regional offices in Europe, Asia and Australia. The company manufactures and sells more than 55,000 products. One of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products, the organization maintains a vast network of global distributors with ISO 13485-certified diagnostic products facilities in Solon, Ohio, Burlingame, Calif. and a distribution centre in Strasbourg, France. MP Biomedicals Asia Pacific Pte Ltd is the Asia Pacific Headquarters located in Singapore manufacturing diagnostics tests for infectious diseases.
MOHH (previously known as Health Corporation of Singapore) is the holding company of Singapore’s public healthcare assets. It operated largely as a dormant holding company until it was recently restructured to address systems-level gaps in our public healthcare system. MOHH today provides systems-level strategising and coordination and facilitates collaboration across clusters/healthcare institutions. In doing so, it enhances overall public healthcare system performance, while ensuring closer alignment to MOH’s vision, mission and priorities. Where possible, MOHH also seeks to leverage on synergies and economies of scale across the entire healthcare spectrum, thereby enhancing operational efficiency of the public healthcare sector in the long run. The healthcare institutions within MOHH are divided into six broad clusters. They include Alexandra Health Pte Ltd, the National Healthcare Group, Jurong Health Services, Singapore Health Services, National University Health System and the Eastern Health Alliance.
The GMP Group is a leading staffing and human resource consultancy in Singapore. With six specialist divisions and a committed team of consultants managing positions across industries and job functions, GMP is poised to help candidates and clients find the right fit. Today, GMP is headquartered in Singapore and maintains a regional network with offices in China, Hong Kong, Malaysia and Thailand.
Bio-REV Pte Ltd, formerly known as Bio-GEN & Asahi Techno Glass, is a leading local supplier of Scientific Bench-top Equipment, Disposable Consumables, Chemical and Biological Reagent products for Life Science/Biotech Research, as well as Pharmaceutical Industries in Singapore.
Product of various brands we represent include ATCCR Genuine Cultures, Primary Cell SolutionsTM, bacteria, clones & viral cultures, Axygen Scientific plastic consumables & disposables; Axygen Biosciences' AxyPrepTM kits, Bioneer RNAi/Oligo synthesis products, ABM Stem Cells reagents and iPSCs inducing viral vectors, StressMarqTM heat shock & cell signaling proteins and antibodies, Iwaki Tissue Culture Plasticwares, Biological Industries sera, Tissue Culture media & reagents, including NitristemTM, Biolog auto bacterial ID & Phenotypic Microarray system and the ever popular Drummond Pipet Aid.
Bio-REV was established in April 2003 under our first name - Bio-GEN, after Asahi Techno Glass Corp (or previously known as Iwaki Glass Co Ltd) ceased operation in Singapore. With a team of highly-motivated staffs who have the knowledge in the areas of biomedical sciences, biotechnology as well as in the field of microbiology and stem cell technologies, Bio-REV is committed to provide the best products and services to our customers.
We are continuously hiring capable and passionate people to join our young sales team for replacement as well as expansion to achieve goals that has been set out. We hope you are the one that will help us. Looking forward to meeting you at the career fair.
If you have any enquiries, feel free to email me at email@example.com